
Table of Contents
ToggleToday, as the Sensex plunges over 1,100 points to around 72,477 and the Nifty50 tests the 22,494 level amid the escalating West Asia conflict and Brent crude surging past $114 per barrel — most Indian investors are glued to their screens watching red tickers. But here’s what the smartest value investors are doing instead: they’re quietly studying gross margin trends of quality businesses to identify which companies will emerge stronger from this crisis.
You see, while everyone obsesses over the P/E ratio or the latest quarterly profit number, the gross margin — and more importantly, its trend over time — is the single most revealing metric about a company’s competitive position. It tells you something no other number can: whether a business is gaining or losing pricing power.
Gross margin is deceptively simple:
Gross Margin (%) = (Revenue − Cost of Goods Sold) ÷ Revenue × 100
It measures what percentage of every rupee of revenue a company keeps after paying for the direct costs of producing its goods or services. If a company earns ₹100 in revenue and spends ₹60 on raw materials, manufacturing, and direct labour, its gross margin is 40%.
But here’s the critical insight that separates amateur investors from professionals: a single gross margin number tells you almost nothing. The TREND over 5-10 years tells you everything.
Think of it like a blood pressure reading. A single reading might be 130/85 — is that good or bad? You need the trend. Is it rising from 120/80? That’s concerning. Is it falling from 150/95? That’s encouraging. The same logic applies to gross margins.
When a company’s gross margin consistently expands over 5+ years, it signals something extraordinary: the business is gaining pricing power faster than its costs are rising. This is the hallmark of a company building or strengthening an economic moat.
Real Indian Example — Asian Paints: Over the past two decades, Asian Paints expanded its gross margins from approximately 38% to over 42% despite raw material (crude-linked) cost volatility. How? Through premiumisation (Royale, SmartCare ranges), dealer network dominance with 70,000+ dealers, and brand power that allows price increases without losing volume. Every time crude oil spiked, Asian Paints absorbed costs temporarily and then passed them through — often with a little extra. That expanding gross margin was the early signal of a stock that turned ₹1 lakh into over ₹1 crore.
What to look for: Gross margin expanding by 50-200 basis points per year consistently. This suggests the company is either (a) shifting to higher-value products, (b) gaining scale advantages, or (c) building brand premium.
Some of India’s finest wealth creators maintain remarkably stable gross margins — within a 2-3 percentage point band over a decade. This signals a mature competitive advantage and disciplined pricing.
Real Indian Example — Hindustan Unilever (HUL): HUL has maintained gross margins in the 50-54% range for over a decade. Despite input cost cycles, competitive pressures, and multiple economic slowdowns, that stability tells you the moat is deep and well-defended. The company’s portfolio of 40+ brands, rural distribution reaching 8 million+ outlets, and premiumisation strategy keep the margin fortress intact.
What to look for: Gross margin fluctuating within a 3% band over 5+ years. This is a company where the competitive dynamics are settled in its favour.
This is the most dangerous pattern and the one most investors miss. When gross margins decline steadily over 3-5 years, it almost always means one of three things: (a) the company is losing pricing power to competitors, (b) raw material costs are structurally rising and the company cannot pass them through, or (c) the business is commoditising.
Real Indian Example — Several textile exporters (2015-2022): Many Indian textile companies that looked “cheap” on P/E showed declining gross margins from 35%+ down to 25% over several years as Chinese and Bangladeshi competitors undercut them on price. Investors who bought based on low P/E ratios alone got trapped in what appeared to be value but was actually a deteriorating business.
Red flag: Gross margin declining by 100+ basis points per year for 3+ consecutive years. This is often a signal to exit, regardless of how cheap the stock looks.
Go to Screener.in, Trendlyne, or Tijori Finance. Pull the annual gross margin (or gross profit/revenue if gross margin isn’t directly shown) for the last 10 years. Plot it on a simple chart or spreadsheet. You’re looking for the trend, not the absolute level.
A 70% gross margin for an IT services company is normal. A 70% gross margin for a commodity steel company would be unprecedented. Always compare apples to apples. For example, within the pharma sector, a company like Divi’s Laboratories maintaining 55-60% gross margins while peers operate at 40-45% tells you something powerful about their API manufacturing efficiency and customer relationships.
The most powerful signal is when gross margins expand while revenue is growing. This means the company is gaining pricing power AND growing volume — the dream combination. If gross margins are only expanding because the company raised prices and lost volume, that’s a very different (and much weaker) story.
Today, with Brent crude at $114.95/barrel and climbing due to the West Asia conflict, raw material dependent companies will see gross margin pressure in the next 1-2 quarters. The question to ask: “Has this company historically recovered its gross margins within 2-4 quarters after a raw material spike?” If yes, the current dip is a buying opportunity. If no, the margin compression may be structural.
I suggest creating a simple scoring system: Award 1 point for each year (out of 10) where gross margin was stable or expanding. A score of 8-10 indicates a company with exceptional pricing power. A score of 5-7 is average. Below 5 is a warning sign. Companies like Titan Biotech (BSE: 524717), currently trading around ₹368 per share, demonstrate the kind of operational discipline in their biotechnology and laboratory chemicals segment that often correlates with sustainable gross margins — where deep domain expertise in agar, peptones, and culture media creates natural barriers to competition.
With the Sensex down 1,100+ points today and widespread panic over the Iran-Israel conflict, here’s the contrarian insight: companies with rising gross margin trends that are falling purely due to market sentiment are the best buys.
During the COVID crash of March 2020, many quality companies with expanding gross margins fell 30-50%. Investors who understood that the margin trends were intact — and that pricing power doesn’t disappear because of a temporary demand shock — made extraordinary returns over the next 3 years.
The same logic applies today. Crude oil at $115 will pressure some margins temporarily, but companies with genuine pricing power (visible through their gross margin history) will recover and thrive.
To help you evaluate gross margins in context, here are rough benchmarks for key Indian sectors:
IT Services: 65-75% gross margins are typical (TCS at ~52% EBIT margin reflects the high gross margin nature of the business). Rising margins here signal better project mix and reduced bench strength.
FMCG: 45-55% is the sweet spot. Companies like Nestlé India and HUL operate at the top. Declining margins here often signal competitive intensity or inability to take price increases.
Pharmaceuticals: 55-70% for branded/specialty players (like Divi’s Labs), 25-40% for generics. The gap tells you who has pricing power and who doesn’t.
Banking: Net Interest Margin (NIM) serves as the banking equivalent of gross margin. With RBI cutting the repo rate to 5.25%, watch for NIM compression — banks that maintain NIMs are demonstrating superior liability franchises.
Specialty Chemicals: 35-50% gross margins with expanding trends signal companies benefiting from the China+1 shift and R&D-driven product evolution.
Biotechnology & Life Sciences: Companies in niche segments like laboratory chemicals and culture media — such as Titan Biotech — often sustain healthy margins due to limited competition and technical barriers. The key is consistency across business cycles.
Here’s a stark reality check: SEBI’s latest study reveals that 91% of individual F&O traders lost money in FY2024-25, with aggregate losses of ₹1,05,603 crore — that’s over ₹1 lakh crore destroyed in a single year. The average per-person loss was ₹1.1 lakh.
Meanwhile, investors who spent just 30 minutes studying gross margin trends of quality businesses — and held them for 5+ years — have consistently built generational wealth. The choice is clear: you can gamble in F&O and join the 91% who lose, or you can learn to read gross margin trends and join the small minority who compound wealth patiently.
As we always say at Multibagger Shares: quality investing beats F&O gambling, every single time.
Here’s your action plan:
1. Pick 5 companies you own or are watching.
2. Pull their 10-year gross margin data from Screener.in.
3. Classify each into Rising Tide, Steady State, or Falling Knife.
4. Ask yourself: “Am I holding any Falling Knife companies just because they look cheap?”
5. For Rising Tide companies currently beaten down by market panic — consider adding more.
To deepen your value investing education, watch our Complete Value Investing Course on YouTube — it’s free, comprehensive, and designed specifically for Indian investors who want to build wealth the right way.
Disclaimer: This article is for educational purposes only and does not constitute financial advice. The author and Multibagger Shares are not SEBI-registered investment advisors. Titan Biotech (BSE: 524717) is mentioned as a case study for educational purposes. Always do your own research and consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Investing in the stock market involves risk, including the potential loss of principal.
📢 Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates — delivered straight to your phone!
✈️ Join @longtermequityy on Telegram
🔔 Free • No spam • Value investing insights daily
Chat with us on WhatsApp